RETROVIR 100 mg/10 ml, oral solution bottle, 200 ml, CIP 3400933884246
Active ingredients: Zidovudine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 200 ml, CIP 3400933884246orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RETROVIR 100 mg/10 ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 200 ml avec seringue pour administration orale de 10 ml polypropylène
- Marketing authorisation holder
- VIIV HEALTHCARE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60524598CIP73388424CIP133400933884246Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZIDOVUDINEsolution | 100 mg · 10 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.